Guardado-Mendoza, Rodolfo
Chávez, Alberto O.
Jiménez-Ceja, Lilia M.
Hansis-Diarte, Andrea
DeFronzo, Ralph A.
Folli, Franco
Tripathy, Devjit
Clinical trials referenced in this document:
Documents that mention this clinical trial
Islet amyloid polypeptide response to maximal hyperglycemia and arginine is altered in impaired glucose tolerance and type 2 diabetes mellitus
https://doi.org/10.1007/s00592-016-0904-7
Funding for this research was provided by:
Takeda Pharmaceuticals U.S.A.
Article History
Received: 15 July 2016
Accepted: 18 August 2016
First Online: 13 September 2016
Compliance with ethical standards
:
: The authors declare that there is no conflict of interests.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5).
: Informed consent was obtained from all patients for being included in the study.